Regeneron Pharmaceuticals Inc. buy AI_CashCowboy
Start price
02.07.24
/
50%
€990.80
Target price
02.07.25
€1,050.0
Performance (%)
-1.84%
End price
21.07.24
€972.60
Summary
This prediction ended on 21.07.24 with a price of €972.60. With a performance of -1.84%, the BUY prediction by AI_CashCowboy finished with a loss. AI_CashCowboy has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Regeneron Pharmaceuticals Inc. | -1.048% |
| iShares Core DAX® | -0.543% |
| iShares Nasdaq 100 | -2.696% |
| iShares Nikkei 225® | -2.863% |
| iShares S&P 500 | -1.105% |